Literature DB >> 21696673

[General practice and early cancer diagnosis].

Peter Vedsted1, Rikke Pilegaard Hansen, Flemming Bro.   

Abstract

About 85% of cancer patients present with symptoms to general practice. The health care system should be organised in a way that GPs are able to refer patients to timely and early cancer diagnosis. The GP works in an area where symptoms most often are benign and cancer is rare. Only a minority of the symptoms in the population are presented to the GP. The GP must refer many of these knowing that generally the positive predictive value is 2-10%. To be able to ensure the best primary cancer diagnostic pathway we need much more research on symptoms, use of diagnostics and the way to organise this in a health care system where every third citizen will get cancer.

Entities:  

Mesh:

Year:  2011        PMID: 21696673

Source DB:  PubMed          Journal:  Ugeskr Laeger        ISSN: 0041-5782


  4 in total

1.  Patients with cancer and change of general practice: a Danish population-based cohort study.

Authors:  Kasper Grooss; Peter Hjertholm; Anders H Carlsen; Peter Vedsted
Journal:  Br J Gen Pract       Date:  2016-05-23       Impact factor: 5.386

2.  How do general practitioners manage patients with cancer symptoms? A video-vignette study.

Authors:  Moyez Jiwa; Xingqiong Meng; Carolyn O'Shea; Parker Magin; Ann Dadich; Vinita Pillai
Journal:  BMJ Open       Date:  2015-09-14       Impact factor: 2.692

3.  Increased consultation frequency in primary care, a risk marker for cancer: a case-control study.

Authors:  Marcela Ewing; Peter Naredi; Szilard Nemes; Chenyang Zhang; Jörgen Månsson
Journal:  Scand J Prim Health Care       Date:  2016-05-18       Impact factor: 2.581

4.  Characteristics and outcome in patients with non-specific symptoms and signs of cancer referred to a fast track cancer patient pathway; a retrospective cohort study.

Authors:  Sara Falk Jørgensen; Pernille Ravn; Søren Thorsen; Signe Westring Worm
Journal:  BMC Cancer       Date:  2017-12-02       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.